Ventriculoperitoneal shunt in treating of idiopathic normal pressure hydrocephalus-single-center study
- 1 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neurochirurgica
- Vol. 162 (1), 1-7
- https://doi.org/10.1007/s00701-019-04135-5
Abstract
Object Idiopathic normal pressure hydrocephalus (iNPH) is the only variant of dementia disorders possibly treatable by neurosurgical intervention. iNPH is a neurodegenerative condition clinically characterized by gait ataxia, urinary incontinence, and memory disturbance. We present one of the largest single-center studies, which was designed to prove efficacy of our low-pressure setting of gravitational valve at all three symptoms of iNPH and to find statistically significant cut-off time for best clinical improvement according to the duration of symptoms. Methods Sixty-one consecutive patients (mean age 74.9 +/- 5.3) with iNPH were prospectively observed from the time of surgery with minimal 6 months follow-up. All patients underwent implantation of the same type of gravitational valve with the same setting-pro GAV with low opening pressure at 5 cm H2O-and were operated by the same team of 2 neurosurgeons. We statistically evaluated gait disturbance, psychological changes, and incontinence preoperatively and at 6 months after surgery and timing of the surgery according to the duration of symptoms and to the age. Results Paired t test showed a statistically significant increase in MMSE, a statistically significant decrease in 10-m walk test and 360 deg. rotation test (p < 0.0001). The correlation among the change of the MMSE, the walk test, and the rotation test, and the age and time of symptoms' duration was verified by Pearson's correlation coefficient. Pearson's correlation coefficient showed a medium strong correlation between the change of MMSE and the time of symptoms (r = - 0.580; p < 0.0001) and between the change of the number of steps and the time of symptoms (r = 0.517, p < 0.0001). There was a statistically significant weak (poor) correlation between the change of the walk test and the time of symptoms (r = 0.351, p = 0.006). All 3 ROC tests confirmed optimal cut-off for the best improvement of symptoms as 9.5 months of the symptom duration. Conclusions We proved statistical significant optimal cut-off for the best improvement of the symptoms as 9.5 months of the symptom duration. This study also confirmed successful treatment of iNPH with VP shunting using low pressure setting of gravitational valve with overall improvement in 75% and low over drainage complications in 5% We proved statistically significant increase in MMSE, decrease in 10 m walk test and number of steps test, p < 0.0001.This publication has 28 references indexed in Scilit:
- Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA)Journal of Neurology, Neurosurgery & Psychiatry, 2013
- One-year outcome in the European multicentre study on iNPHActa Neurologica Scandinavica, 2012
- Indications for Endoscopic Third Ventriculostomy in Normal Pressure HydrocephalusActa neurochirurgica. Supplement, 2011
- Five-year incidence of surgery for idiopathic normal pressure hydrocephalus in NorwayActa Neurologica Scandinavica, 2009
- Endoscopic third ventriculostomy in the management of communicating hydrocephalus: a preliminary studyJournal of Neurosurgery, 2008
- Normal pressure hydrocephalus: long-term outcome after shunt surgeryJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Multiple organ infection and the pathogenesis of SARSThe Journal of Experimental Medicine, 2005
- Radiological assessment of hydrocephalus: new theories and implications for therapyNeurosurgical Review, 2004
- Dutch Normal-Pressure Hydrocephalus Study: randomized comparison of low- and medium-pressure shuntsJournal of Neurosurgery, 1998
- An evaluation of the cerebrospinal fluid infusion test for hydrocephalusNeurology, 1971